{name}
{subtitle}
Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)
city
~85 mi. (Yekaterinburg, Russia, +93 more cities)
facility
Sverdlovsk Regional Oncology Hospital ( Site 0867), +1 more facility
condition
Bladder Carcinoma, +1 more condition
drug
cisplatin, +4 more drugs
drug type
chemotherapy, +3 more types
Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Cisplatin-ineligible Participants With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)
city
~85 mi. (Yekaterinburg, Russia, +163 more cities)
facility
Sverdlovsk Regional Oncology Hospital ( Site 0874)
drug
cystectomy, +2 more drugs
drug type
chemotherapy, +3 more types
Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)
city
~85 mi. (Yekaterinburg, Russia, +158 more cities)
facility
Sverdlovsk Regional Oncology Hospital ( Site 1909)
drug
olaparib, +4 more drugs
drug type
chemotherapy, +3 more types
Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)
city
~85 mi. (Yekaterinburg, Russia, +122 more cities)
facility
Sverdlovsk Regional Oncology Hospital ( Site 1807)
drug
etoposide, +5 more drugs
drug type
chemotherapy, +3 more types
Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867)
city
~85 mi. (Yekaterinburg, Russia, +145 more cities)
facility
Sverdlovsk Regional Oncology Hospital ( Site 2012)
drug
pembrolizumab, +1 more drug
drug type
immunotherapy, +2 more types